Canada markets close in 1 hour 20 minutes

Oncolytics Biotech Inc. (ONC.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
2.8300-0.1400 (-4.71%)
As of 02:39PM EDT. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) 217.91M
Enterprise Value 194.03M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)9.80
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -6.91

Trading Information

Stock Price History

Beta (5Y Monthly) 1.74
52-Week Change 373.68%
S&P500 52-Week Change 316.57%
52 Week High 34.4900
52 Week Low 31.4800
50-Day Moving Average 33.0960
200-Day Moving Average 32.5286

Share Statistics

Avg Vol (3 month) 3173.9k
Avg Vol (10 day) 394.62k
Shares Outstanding 573.37M
Implied Shares Outstanding 673.86M
Float 871.53M
% Held by Insiders 11.33%
% Held by Institutions 11.91%
Shares Short (Sept 14, 2023) 4295k
Short Ratio (Sept 14, 2023) 42.32
Short % of Float (Sept 14, 2023) 40.41%
Short % of Shares Outstanding (Sept 14, 2023) 40.40%
Shares Short (prior month Aug 14, 2023) 4234.44k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 24, 2018
Ex-Dividend Date 4N/A
Last Split Factor 2105:1000
Last Split Date 3May 24, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Jun 29, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-49.27%
Return on Equity (ttm)-101.26%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -28.38M
Net Income Avi to Common (ttm)-26.84M
Diluted EPS (ttm)-0.4400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)24.35M
Total Cash Per Share (mrq)0.34
Total Debt (mrq)479k
Total Debt/Equity (mrq)2.15%
Current Ratio (mrq)11.69
Book Value Per Share (mrq)0.34

Cash Flow Statement

Operating Cash Flow (ttm)-26.48M
Levered Free Cash Flow (ttm)-16.23M